STEPUPIORS supported Webinar

During the Scientific Day 2024 of the Serbian Association for Cancer Research Prof. Antoni Castells from Hospital Clínic de Barcelona delivered a STEPUPIORS supported Webinar:  “Colorectal cancer screening: great opportunities and new challenges”
The meeting was attended by Serbian and international researchers from various institutions, leading to vivid discussions on this globally important topic with insight from different countries.




Open Day on colorectal cancer

On March 25, the IORS hosted an Open Day focused on colorectal cancer. The event aimed to raise awareness, support affected individuals, and emphasize the importance of prevention and early detection. It featured oncology experts, medical professionals, representatives from patient associations, and a genetic counselling team. Attendees heard a patient’s experience with treatment and genetic testing for hereditary syndromes, while discussions covered prevention, symptoms, diagnosis, treatment, and rehabilitation of colorectal cancer.




STEPUPIORS lectures at TRANSLACORE COST Action webinar

The 6th Webinar “Cancer medicine – Rectal Cancer Predictive Biomarkers” organized by the Early Career Investigators network under the TRANSLACORE COST Action was held on Monday, April 22nd and featured STEPUPIORS lecturers Milena Cavic, Mladen Marinkovic and Aleksandra Stanojevic.

Τhe webinar focused on the following lectures:

“Rectal Cancer Predictive Biomarkers – STEPUPIORS Horizon Europe Project” by Milena Cavic, IORS

“Pretreatment MRI Radiomics in Rectal Cancer Chemoradiotherapy Prediction” by Mladen Marinkovic, IORS

“In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer” by Aleksandra Stanojevic, IORS

The meeting was moderated by Dr Paulina Podszywalow-Bartnicka from the

Nencki Institute of Experimental Biology, Warsaw, Poland. Exciting discussions were held and new collaborations formed from this new network dedicated to bridging disciplines and expertise across Europe in order to advance translational control in cancer.



Midterm Review Meeting

On March 18, 2024, the STEPUPIORS consortium had a Midterm Review Meeting with the Project Officer Dr Irimie Doru-Leonard of the Research Executive Agency, European Commission, and an External Monitor Prof. Roman Volchenkov, from the University of Oslo, Norway. Main project results, deliverables, milestones and future plans were outlined by work package leaders and project managers from all partner institutions, in a friendly and stimulating atmosphere. The midterm report was approved by the REA EuC and the consortium participants look forward to next project steps.

 

STEPUPIORS midterm review participants:

Dr Ana Krivokuca, IORS, WP1 co-leader1
Dr Miljana Tanic, IORS, WP1 co-leader2
Dr Radmila Jankovic, IORS, WP2 leader
Prof. Ieronymos Zoidakis, BRFAA, WP3 leader
Dr Sergi Castellví-Bel, FRCB-IDIBAPS, WP4 leader
Dr Milena Cavic, IORS, WP5 leader/Project Coordinator
Dr Remond Fijneman, NKI-AVL PI
Dr Ana Djuric, IORS Project manager
Dr Meike de Wit, NKI-AVL Project manager
Dr Christos Ilioudis, BRFAA Project manager
Dr Joan Pallares, FRCB-IDIBAPS Project manager



STEPUPIORS at AACR2024 Congress

STEPUPIORS PIs Milena Cavic and Remond Fijneman presented latest project results and advancements in the colorectal cancer and liquid biopsy field at the science-packed AACR24 Congress of the American Association for Cancer Research, held from Apr 05-10, 2024 in San Diego, USA. Exciting discussions and plans for future projects on colorectal cancer predictive biomarkers were made with various stakeholders.
Cavic M, Djuric A, Marinkovic M, Stanojevic A, Tanic M, Bjelogrlic S, Spasic J, Damjanovic A,  Djordjic Crnogorac M, Vuletic A, Mirjacic Martinovic K, Radulovic M, Stojanovic-Rundic S, Krivokuca A, Jankovic R, Castellvi-Bel S, Zoidakis J, Fijneman R. Employing widening funds to address inequity in cancer research – example of the STEPUPIORS collaborative rectal cancer project [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1304.https://doi.org/10.1158/1538-7445.AM2024-1304.

https://aacrjournals.org/cancerres/article/84/6_Supplement/1304/738874/Abstract-1304-Employing-widening-funds-to-address